Profilo
Esper Boel is currently a Director at MonTa Biosciences ApS.
Prior to this, he held positions as Head-Biotechnology Unit at Novo Nordisk A and Senior Vice President & Head-Discovery at Symphogen A. Boel received his undergraduate and doctorate degrees from the University of Aarhus in 1979.
Posizioni attive di Esper Boel
| Società | Posizione | Inizio |
|---|---|---|
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Esper Boel
| Società | Posizione | Fine |
|---|---|---|
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Direttore Tecnico/Scientifico/R&S | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formazione di Esper Boel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Health Technology |
















